Company intelligence / Profile preview

Labiotre

Tavarnelle Val di Pesa, Tuscany, Italy

Ownership: Private
Development stage: Other

Overview

Labiotre specializes in producing high-standardized, innovative botanical extracts for nutraceutical and health supplement use, with exclusive clinical studies performed on specific extracts at customer request. No clinical drug trial results, as the company operates in the supplement/raw ingredient sector.

Modalities: Small moleculeBotanical extractPlant-based product
Industry: Food & Nutrition

Partnerships

Labomar (majority/acquiring owner since 2021)

Beyond the preview

Go deeper on Labiotre.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Labiotre.

Explore the full profile